Kymera Therapeutics, Inc. · NASDAQ:KYMR
The Vanguard Group reported a 8.05% stake in Kymera Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 30, 2025
The Vanguard Group reported a 8.05% stake in Kymera Therapeutics, Inc., 5,231,392 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G/A).
- Stake
- 8.05%
- Shares
- 5,231,392
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 8.05% | 5,231,392 |
Source
Related
- Kymera Therapeutics, Inc.
- The Vanguard Group
- Kymera Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2026
- Form 4 · Adams Brian · Sep 4, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Atlas Venture Fund X, L.P. · Aug 13, 2026